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Experimental Hypoxia and Embryonic
Angiogenesis†
O. Naňka,1* P. Valášek,1,2 M. Dvořáková,3 and M. Grim1
We examined the role of hypoxia and HIF factors in embryonic angiogenesis and correlated the degree of
hypoxia with the level of HIF and VEGF expression and blood vessel formation. Quail eggs were incubated
in normoxic and hypoxic (16% O2) conditions. Tissue hypoxia marker, pimonidazol hydrochloride, was
applied in vivo for 1 hr and detected in sections with Hypoxyprobe-1 Ab. VEGF and HIF expression was
detected by in situ hybridization. HIF-1 protein was detected in sections and by Western blot. Endothelial
cells were visualized with QH-1 antibody. Hypoxic regions were detected even in normoxic control embryos,
mainly in brain, neural tube, branchial arches, limb primordia, and mesonephros. The expression patterns
of HIF-1 and HIF-1 factors followed, in general, the Hypoxyprobe-1 marked regions. HIF-2 was
predominantly expressed in endothelial cells. Diffuse VEGF expression was detected in hypoxic areas of
neural tube, myocardium, digestive tube, and most prominently in mesonephros. Growing capillaries were
directed to areas of VEGF positivity. Hypoxic regions in hypoxic embryos were larger and stained more
intensely. VEGF and HIF-1 factors were proportionately elevated in Hypoxyprobe-1 marked regions
without being expressed at new sites and were followed by increased angiogenesis. Our results demonstrate
that normal embryonic vascular development involves the HIF-VEGF regulatory cascade. Experimentally
increasing the level of hypoxia to a moderate level resulted in over-expression of HIF-1 factors and VEGF
followed by an increase in the density of developing vessels. These data indicate that embryonic
angiogenesis is responsive to environmental oxygen tension and, therefore, is not entirely genetically
controlled. Developmental Dynamics 235:723–733, 2006. © 2006 Wiley-Liss, Inc.
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INTRODUCTION
Blood vessels develop during embryo-
genesis either by vasculogenesis (de
novo formation from precursor cells)
or by angiogenesis (from pre-existing
vessels) (Risau, 1997). These pro-
cesses are in part controlled by vascu-
lar endothelial growth factor (VEGF).
It has recently been shown that VEGF
exists in five forms designated VEGF
A, B, C, D, E. Also three members of
the VEGF receptor family, VEGFR1
(Flt-1), VEGFR2 (KDR/Flk-1/Quek 1),
and VEGFR3 (Flt-4/Quek 2), were
identified with unique characteristics
in terms of regulation of angiogenesis
and vascular permeability (Weinstein,
1999).
Evidence that hypoxia resulting
from increased metabolic demands
triggers angiogenic factors was first
provided by experiments on growing
tumors (Folkman et al., 1971). Cells at
low oxygen tension express hypoxia-
induced transcription factor, HIF-1
(Semenza and Wang, 1992; Forsythe
et al., 1996). Furthermore, this factor
is relatively stabilized under hypoxia,
as HIF-1 hydroxylase, which starts
the degradation pathway, requires ox-
ygen (Brahimi-Horn et al., 2001). Un-
degraded HIF-1 then translocates to
the nucleus where it forms HIF-1
†This article was accepted for publication in Developmental Dynamics 235#1–Cardiovascular Special Issue
1Institute of Anatomy, Charles University First Faculty of Medicine, Prague, Czech Republic
2Royal Veterinary College, London, United Kingdom
3Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic
Grant sponsor: Ministry of Education of The Czech Republic; Grant numbers: VZ 1111 00003-3 and 0021620806.
*Correspondence to: Ondrej Nanka, Institute of Anatomy, Charles University First Faculty of Medicine, U nemocnice 3,
CZ-128 00 Prague 2, Czech Republic. E-mail: ondrej.nanka@lf1.cuni.cz
DOI 10.1002/dvdy.20689
Published online 27 January 2006 in Wiley InterScience (www.interscience.wiley.com).
DEVELOPMENTAL DYNAMICS 235:723–733, 2006
© 2006 Wiley-Liss, Inc.
transcription factor by dimerising
with HIF-1 (ARNT) that is expressed
constitutively. One of the first de-
scribed angiogenic factors that are
regulated by HIF-1 is VEGF (Shweiki
et al., 1992). HIF-1 not only activates
VEGF expression but also other genes
that increase O2 delivery such as
erythropoetin and glycolytic enzymes
(reviewed by Blancher and Harris,
1998). HIF-2 is also induced by hyp-
oxia and again together with HIF-1
binds the regulatory regions of hyp-
oxia responsive genes (Tian et al.,
1997; Kappel et al., 1999; Ema et al.,
1997).
The measurements of oxygen ten-
sion in organ primordia of 4- and
6-day-old chick embryos have shown
very low values. Using oxygen micro-
electrodes, Meuer and Baumann
(1987) and Meuer et al. (1992) showed
that tissue pO2 values ranged be-
tween zero and 5.9 kPa in arterial
blood. About half of the obtained val-
ues were lower than 0.65 kPa. The
oxygen tension in brain was 2 and 0.7
kPa in wing and limb buds (Meuer et
al., 1992). Areas of tissue hypoxia in
fast-growing organ primordia thus
could represent a physiological stimu-
lation of angiogenesis via HIF-in-
duced VEGF. Immunohistochemical
detection of tissue hypoxia using pi-
monidazole (Raleigh et al., 1998) re-
veals hypoxic regions and allows for
correlation with the level of expres-
sion of genes participating in this cas-
cade. Pimonidazol forms immunologi-
cally detectable adducts only in
tissues with partial oxygen tension be-
low 1.3 kPa (10 mm Hg). The critical
pO2 for efficient oxidative metabolism
in mitochondria is 0.133 kPa of O2
(Chance et al., 1962; Chance and Wil-
liams, 1955). Currently, there are only
a few studies demonstrating hypoxic
regions in embryonic organ primordia
using bioreductive markers of hyp-
oxia. Lee et al. (2001) used pimonida-
zol for analysis of the role of tissue
hypoxia in mouse embryos. Catron et
al. (2001) described an increase in co-
valent binding of 3H-misonidazole in
chick heart (ED9) exposed to chronic
hypoxia and Sugishita et al. (2004)
used nitroimidazol EF5 for detection
of hypoxic region of the embryonic car-
diac outflow tract in chick and quail.
Lee et al. (2001) used normal mouse
embryos to analyze the hypoxia as a
possible signal for vessel develop-
ment. We decided to extend this type
of study using experimental hypoxia
in a model of avian embryos. Our
study includes the detection of all HIF
factors and deploys the QH1 antibody
as quail endothelia specific marker.
Quail eggs were incubated not only
under normal condition but also at
lower pO2 tensions to test to what ex-
tent the hypoxia could be efficient in
stimulation of angiogenesis. Our data
show that areas of tissue hypoxia in
fast-growing embryonic organ primor-






Preliminary experiments with hyp-
oxia from the beginning of incubation
always resulted in non-viable embryos
at 48 hr. Our further experiments
therefore started the hypoxic condi-
tions from ED2 onwards. On ED4, af-
ter 2 days of hypoxia, the majority of
embryos was viable and on ED6 (after
4 days of hypoxia) approximately 2/3
were viable. The longest period of sur-
vival was 9 days. The embryos that
did not survive showed diffuse subcu-
taneous bleeding but no macroscopic
malformations. Embryos incubated
under hypoxic conditions were usually
larger than the controls. The size dif-
ference was more prominent at ED6
than at ED4, however the individual
variability was great. By determining
the total protein content in some em-
bryos it was verified, that the weight
elevation was caused by edema.
Hypoxic Regions in
Normoxic Embryos
Hypoxyprobe 1 detects the tissue hyp-
oxia when pO2 is less than 1.3 kPa (10
mm Hg) (Raleigh et al., 1998). Low
diffuse staining intensity was ob-
served in all tissues of the body (Fig.
1A). The higher intensity of staining
was detected in some organ primordia
including lungs, liver, neural tube,
mesonephros, myocardium, and in
branchial arches at ED4 (Fig. 1F).
Limb primordia at ED4 exhibited hyp-
oxia in subectodermal layer of mesen-
chyme, especially under the apical ec-
todermal ridge (Fig. 2G).
ED6 embryos displayed hypoxic ar-
eas within the whole extent of lung
and liver, in gray matter of the neural
tube, in proximal tubules and glomer-
uli of mesonephros, in Wolffian duct,
in septal myocardium, in mucous and
muscular layers of digestive tube, and
in muscle primordia of limbs (Fig.
3I,M,Q).
Hypoxic Regions in Hypoxic
Embryos
The staining intensity of Hypoxyprobe
reaction in hypoxic conditions was
much higher than in normoxic condi-
tion. The hypoxic areas became larger
and were observed everywhere where
organ primordia were formed by
densely packed cells (Fig. 1B). They
were more pronounced in ED6 than in
ED4 embryos (Figs. 2E, 3K,O,S). In
limb primordia of ED6 embryos, hy-
poxic regions included perichondrium
and primordia of tendons and muscles
(Figs. 2I, 3W).
Expression of HIF Factors
at ED 4 in Normoxia
The HIF-1 and HIF-1 mRNA were
expressed under normoxic conditions
at high levels in numerous localiza-
tions, including the neuroepithelium
of the brain vesicles, in the sub-
ependymal layer of the neural tube, in
ventral parts of dermomyotomes, and
in auditory vesicle, inner retina layer,
branchial arches 1 and 2 (Fig. 1G),
limb primordia, and cloacal region.
The signal was weak and diffusely
distributed in limb primordia (Fig.
1C,O).
HIF-2 expression was found only
in the endocardium and endothelium
of blood vessels: in the dorsal aorta,
arteries of branchial arches, inter-
somitic vessels (Fig. 1Q), and vessels
of mesonephros.
Detection of HIF-1 protein in sec-
tions showed weak activity in nor-
moxic embryos, especially in myocar-
dium, liver, and mesonephros (Fig.
1I).
Expression of HIF Factors
at ED 4 in Hypoxia
The HIF-1 and HIF-1 mRNA ex-
pression under hypoxic conditions ex-
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Fig. 1. Hypoxia and HIF gene expression at ED4 in normoxic (n) and hypoxic (h) embryos. A,B: Hypoxic regions detected with Hypoxyprobe-1 on
transverse sections of normoxic (A) and hypoxic embryos (B). Blue reaction product is visible in proximal tubuli of mesonephros (arrows), liver primordia
(L), developing heart, neural tube, and limb buds. Note the stronger intensity of reaction in hypoxic embryo. C,D: HIF-1 mRNA expression in normoxic
(C) and hypoxic (D) embryo. Strong signal in branchial arches, weaker signal in limb and in brain. Note distinct localisation in limb primordia of hypoxic
embryo (arrows). E: Expression of HIF-1 mRNA in axial structures of a limb bud in a hypoxic embryo (section from D). F–H: Sections of branchial
arches. Detection of tissue hypoxia in hypoxic embryo (F). HIF-1 mRNA expression in normoxic (G) and hypoxic (H) embryo. Counterstaining with
nuclear red (G, H). I,J: Immunohistochemistry of HIF-1 protein expression in transverse section of normoxic (I) and hypoxic (J) embryo. The staining
intensity is stronger in tissues of hypoxic embryo (J). Note stronger intensity of reaction in liver (L), heart (H), and proximal tubuli of mesonephros
(arrow). Counterstaining with hematoxylin. K–N: Details of organs from hypoxic embryo (J), neural tube (K), myocardium (L), liver (M), and mesonephros
(N). The protein is localized in cytoplasm and in nuclei (arrows). O,P: HIF-1 mRNA expression in normoxic (O) and hypoxic (P) embryo. Note distinct
localisation and stronger positivity in limb primordia of hypoxic embryo (arrows). Q,R: Expression of HIF-2 mRNA in endothelial cells of normoxic (Q)
and hypoxic (R) embryo. Note dorsal aorta, intersomitic vessels, vessels of the branchial arches, subcutaneous plexuses, and endocardium. S:
Transverse section of whole mount HIF-2 mRNA in situ hybridized embryo shows signal in aortic endothelium. Counterstaining with nuclear red.
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Fig. 2. VEGF expression, detection of hypoxia, and visualization of capillaries in normoxic (n) and hypoxic (h) embryos at ED4 and ED6 (C–F). A,B:
Ventral views of dissected mesonephros. ISH for VEGF mRNA in normoxic (A) and hypoxic (B) embryos. Note increased VEGF expression under
hypoxic conditions. C–F: Sections of mesonephros at ED 6. VEGF (blue) is expressed in podocytes (C, F) (arrowheads) but not in tubules. Numerous
simultaneously immunostained glomerular capillaries (brown) are likely to be stimulated in growth by VEGF from podocytes (C, F). The Hypoxyprobe-1
detects hypoxia in proximal tubules (D) and in podocytes (arrowheads) (E). G–J: Sections of limb primordia. Hypoxic regions (G, I) and visualization
of capillaries by QH1-Ab (H, J) in the developing wing in normoxic (G, H) and hypoxic (I, J) embryos. Hypoxia is more pronounced in developing
marginal sinus. K–N: Subcutaneous intersomitic vessels stained with QH-1 antibody on dorsal (K, L) and lateral (M, N) aspects of ED 4 normoxic (K,
M) and hypoxic (L, N) embryos. Vascular plexuses are richer in hypoxic embryos.
hibited similar localization as in nor-
moxic embryos (Fig. 1C,D,O,P).
However, the intensity of expression
of both factors was higher and areas of
positivity were larger. These differ-
ences were pronounced in limb pri-
mordia, mainly in the subectodermal
mesenchyme and in a strip in the axis
of zeugopodial limb segment (Fig. 1E).
The strip ends distally by a dot of pos-
itivity in the autopodial segment (Fig.
1D,P). This strip corresponds to the
position of the main arterial trunk at
ED6. There were no differences in ex-
pression of HIF-2 in endothelium
and endocardium under hypoxic and
normoxic conditions (Fig. 1Q–S).
The visualization of HIF-1 protein
in sections (Fig. 1J) has shown an in-
creased activity especially in neural
tube (Fig. 1K), myocardium (Fig. 1L),
liver (Fig. 1M), mesonephros (Fig.
1N), and in muscle primordia. The re-
action product was localized in cyto-
plasm and in nuclei. Western blot
analysis suggests an approximately
2–3 times higher amount of HIF-1
protein in hypoxic embryos (Fig. 4).
This observation is consistent with
known HIF-1 stabilization due to in-
creased hypoxia.
Expression of HIF Factors
at ED 6 in Normoxia
The highest level of HIF-1 and
HIF-1 mRNA expression at ED6 was
observed in brain vesicles, especially
in mesencephalon, in the subependy-
mal zone of neural tube, in otic vesicle,
and in the mandibular process. The
level of HIF-1 and  expression in
the heart is low. The signal in the
trunk is visible in the dorsal and ven-
tral parts of myotomes. The strip of
expression of HIF-1 and , visible in
the axis of zeugopodium, has at ED6
shifted distally in rays of digit primor-
dia (Fig. 3C,E). Areas of high staining
intensity in stylopodium and zeugopo-
dium correspond to muscle primordia
(data not shown). The HIF-2 expres-
sion in the endothelium of blood ves-
sels remained unchanged (Fig. 3G).
Expression of HIF Factors
at ED 6 in Hypoxia
The expression of HIF-1 factors
mRNA was elevated under hypoxic
conditions when compared with nor-
moxia. It remained restricted to their
original sites, without expression at
new sites (Fig. 3D,F).
The increased overall HIF-2 ex-
pression correlated to the increased
vascular density. However, the ex-
pression remained localized to the en-
dothelium of blood vessels and was of






VEGF expression was found in meso-
nephros primordium at ED4 (Fig.
2A,B) and more specifically in podo-
cytes at ED6. This expression was
stronger in hypoxia and was in both
instances accompanied with QH1-pos-
itive endothelia (Fig. 2C,F). In addi-
tion, weak VEGF expression was vis-
ible in proximal tubules in hypoxia
and the tubules were also positive for
Hypoxyprobe (Fig. 2D). They were
surrounded by rich capillary plexuses
in sections simultaneously stained
with QH1 Ab (Fig. 2C). This arrange-
ment in mesonephros thus suggests
that growth of capillaries in mesone-
phros is stimulated by hypoxia and
VEGF. This was most obvious on the
glomerular capillaries where hypoxic
podocytes produce VEGF (Fig. 2E,F).
Neural tube.
ISH of the neural tube was positive for
VEGF expression in the whole extent
of the gray matter in normoxic ED4
and ED6 embryos. The spinal cord
was surrounded by a capillary plexus.
In hypoxic embryos, the VEGF expres-
sion was more intense in anterior
horns and in basal plate than in the
remaining parts of the tube. The basal
plate area appeared to be the site of
entry of vessels in the neural tube
(Fig. 3I–L).
Digestive tract.
Cross-sections of the intestine showed
distinct differences in the level of
staining with Hypoxypobe and VEGF
expression between normoxic and hy-
poxic embryos. In contrast to nor-
moxic embryos, the mucous and mus-
cular layer of intestine was strongly
positive in both stains under hypoxia.
The vascularization of the intestinal
wall at ED6 of hypoxic embryos was
markedly more developed than in the
normoxic embryos. Hypoxia thus in-
duced acceleration of angiogenesis in
the wall of the intestine. A similar
effect of the hypoxic condition was ob-
served in the liver primordium (Figs.
1A,B, 3M–P).
Heart.
Marked differences between normoxic
and hypoxic myocardium were ob-
served at ED6. Hypoxia caused exces-
sive trabecularization of ventricular
myocardium. Hypoxic regions were
visible in septal and superficial (epi-
cardial side) parts of myocardium and
stained more intensely under hypoxia.
A much higher level of VEGF expres-
sion was visible in the whole extent of
myocardium in hypoxic embryos than
in the normoxic ones (Fig. 3Q–T). This
effect was especially pronounced in
the interventricular septum, where
increased VEGF expression was fol-
lowed by higher vasularization (Fig.
3U,V).
Limbs.
VEGF expression at ED4 and ED6
was diffuse and low. Under hypoxic
conditions, the VEGF was elevated at
both ED4 and ED6. At ED6, the high
VEGF expression was visible in mus-
cle and tendon primordia and in car-
tilage forming the skeleton primordia.
Capillary plexuses formed around
these primordia (Fig. 3X,Y).
Superficial capillary plexuses.
Comparison of the density of sub-
epidermal capillary plexuses in nor-
moxic and hypoxic embryos in whole
mounts stained with QH1 antibody al-
lows for the evaluation of the extent of
more intense angiogenesis caused by
hypoxia.
The intersomitic capillary plexuses
on the dorsal and lateral aspects of the
trunk and on the dorsal aspects of de-
veloping limbs (Fig. 2J,L,N) were
more dense in hypoxic embryos, than
in normoxic ones (Fig. 2H,K,M).
DISCUSSION
Our results demonstrated the extent
of embryonic tissue hypoxia under
normal conditions during develop-
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ment in liver, mesonephros, neural
tube, heart, and limb primordia. Un-
der hypoxic conditions, the staining
intensity of hypoxic regions increased
and the areas of staining became
broader. There was a temporal and
spatial correlation between the tissue
hypoxia (Fig. 3A,B) and the increased
expression of HIF-1 factors followed
by VEGF expression and increased
angiogenesis. The newly formed ves-
sels were oriented to the regions of
increased VEGF expression. Expres-
sion of HIF-2 reflected the increased
vascular density but remained of the
same intensity. Generally, we have
shown the effect of hypoxia on the ini-
tiation of signaling cascade: increased
HIF-1 mRNA 3 stabilization of
HIF-1 protein by hypoxia 3 VEGF
3 angiogenesis. It was markedly pro-
nounced in the intestinal wall, meso-
nephros, neural tube, and developing
limbs.
Markers of Hypoxia
A method for determination of tissue
oxygenation that has found wide ac-
ceptance is polarographic O2 Eppen-
dorf histography (Meuer et al., 1992;
Meuer and Baumann, 1987; Vaupel et
al., 1989). Its invasive nature limits
the measurement to easily accessible
tissues. An alternative approach is the
measurement of tissue hypoxia. Nitro-
imidazole derivatives EF5 (Evans et
al., 1995) and pimonidazole (Raleigh
et al., 1998) form immunologically de-
tectable adducts in hypoxic tissues.
Pimonidazole, in contrast to EF5, has
the benefit of prolonged lifetime of the
adduct and low toxicity. The use of
pimonidazol has been validated in
both tumor and normal tissues (Ra-
leigh et al., 1998; Lee et al., 2001).
Limitation of the use of injected sub-
stances is that they do not diffuse suf-
ficiently in tissues that are not vas-
cularised. This is, however, not an
issue in young embryonic stages
used in our experiments. We were,
thus, able to document the matching
of hypoxic regions with HIF-1 ex-
pression pattern.
Fatal Initial Hypoxia,
Edema, VEGF, and Blood
Vessel Permeability
Our preliminary experiments showed
that the oxygen tension of 16 kPa (
16% O2) from the beginning of incuba-
tion is lethal for all quail embryos. In
contrast, the hypoxia permitted the
development of the majority of em-
bryos when introduced from the 3rd
day of incubation, i.e., from the day
when the area vasculosa starts to
function as the respiratory organ (Ci-
rotto and Arangi, 1989).
The regimen of introducing hypoxia
on the 3rd day of development has
also been used by others (Adair et al.,
1987, 1988; Mancini et al., 1991; Bur-
ton and Palmer 1992).
Edema with the resulting increase
of weight is likely explained by in-
creased expression of VEGF. This
growth factor was originally called
vascular permeability factor accord-
ing to its first observed effect (Senger
et al., 1983). It is worth noting that
chick embryos in our preliminary ex-
periments were even more susceptible
to the hypoxic conditions than the
quail embryos, and we did not find any
period of 16 kPa hypoxia, which would
permit their embryonic development.
Physiological Embryonic
Tissue Hypoxia and the
Effect of Hypoxic Conditions
Rapid growth of embryonic tissue and
the resulting intensity of metabolic
processes represent enhanced de-
mands for oxygen supply. Hypoxic re-
gions observed in our study in quail
embryos (neural tube, myocardium,
mesonephros, liver, digestive tube)
correspond to those observed in nor-
moxic mouse embryos (Lee et al.,
2001). In addition, we found hypoxic
regions in branchial arches and limb
primordia that were not analyzed in
mouse by Lee et al. (2001).
Previous results have shown that
HIF-1 mRNA and protein expression
are tightly coupled to O2 concentra-
tion in different organs of adult rats or
mice (Wiener et al., 1996; Yu et al.,
1998). The oxygen tension in embry-
onic organ primordia is much lower
than in adults (Meuer et al., 1987,
1992). It is, therefore, not surprising
Fig. 4. Immunoblot of HIF-1 protein from
whole normoxic and hypoxic quail embryo at
ED 4.
Fig. 3. Tissue hypoxia, HIF, and VEGF expression in normoxic (n) and hypoxic (h) embryos at ED 6. A, B: Expression of VEGF mRNA is higher in hypoxic
embryo (B) than in embryo incubated at normoxia (A). C, D: Expression of HIF-1 mRNA in normoxic (C) and hypoxic (D) embryo. Expression is higher
in hypoxic embryo. E, F: Expression of HIF-1 mRNA in normoxic (E) and hypoxic (F) embryo. Expression is higher and areas of positivity are larger
in hypoxic embryo. G, H: Expression of HIF-2 mRNA in endothelium of blood capilaries of normoxic (G) and hypoxic (H) embryos. The development
of capillary plexuses is more advanced in hypoxic embryo. I–L: Transverse sections of the neural tube stained with Hypoxyprobe (I,K) or double stained
with QH-1 Ab (brown) and by ISH for VEGF mRNA (blue) (J,L). Tissue hypoxia is more pronounced in grey matter of hypoxic embryo (K) than in the
control (I). Correspondingly, in hypoxic embryo (L), the VEGF expression is higher and capillary plexuses are richer than in normoxia (J). M–P:
Transverse sections of digestive tube show discrete rings of tissue hypoxia (M, O) and corresponding VEGF expression (N, P) in the mucous membrane
and the muscular layer of the tube. Note their increased levels (O, P) and richer capillaries (P) in hypoxic embryo in comparison with control (M, N).
Some capillaries start to grow into the muscular layer (P). Q–T: Section of heart ventricles stained with Hypoxyprobe (Q, S) or with QH-1 Ab (brown)
and by ISH for VEGF (R, T). Tissue hypoxia is detected in ventricular wall and interventricular septum of normoxic specimen (Q). In hypoxic embryo,
these areas are larger and include also trabecular myocardium (S). VEGF expression is elevated in hypoxic myocardium (T). Note richer trabecular-
ization of myocardium in hypoxic embryo (S, T). U, V: Details (from R, T) of interventricular septum. Note the increased vascularization in hypoxic
septum (V) in comparison to normoxic one (U). W–Y: Longitudinal (W) and transverse (X, Y) sections of limbs stained with Hypoxyprobe (W) or with
QH-1 Ab (brown) and by ISH for VEGF (X, Y). In hypoxic limbs, the tissue hypoxia (W) and VEGF expression (Y) are detected in primordia of muscles
(m), tendons, and cartilages (c) that are surrounded by capillary plexuses. In normoxic embryo (X), the level of VEGF expression is lower. Muscle
primordia are still avascular at ED6.
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Fig. 3.
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that the basal levels of HIF-1 mRNA
and protein were relatively high. Their
expression increased under experimen-
tal induced hypoxia. The observed in-
crease of HIF-1 protein under hy-
poxic conditions is likely to be a result
of both its increased mRNA levels and
its stabilization due to the decreased
activity of HIF-1 hydroxylase (Bra-
himi-Horn et al., 2001).
All hypoxic regions are character-
ized by expression of HIF-1 mRNA
and protein and by VEGF expression
that is followed by vessel formation. It
has been previously shown that ex-
pression of VEGF induced by hypoxia
is instrumental in vascularization of
the developing kidney in vitro in rat
metanephric organ cultures (Tufro-
McReddie et al., 1997). Glomerular
podocytes are particularly rich
sources of VEGF (Freeburg et al.,
2003). Our experimental hypoxia led
to a strong elevation of VEGF expres-
sion that was not observed to such an
extent in any other organ primordia.
Thus, mesonephros appears to be the
most sensitive embryonic organ with
respect to VEGF production in reac-
tion to a hypoxic environment.
Quail embryos demonstrated ele-
vated expression of both HIF-1 and
HIF-1 under hypoxic conditions. In
contrast, the expression of HIF-1 in
hypoxic mouse embryos was not influ-
enced by hypoxia (Wang et al., 1995).
Whether this represents a difference
between in ovo and in utero develop-
ment remains to be determined.
The observed hypoxic regions with
distinct HIF expression were the same
regions that were defective in the
mouse HIF-1 null mutant. These in-
cluded hypoplastic or absent vessels
in the head, in the branchial arches,
and along the dorsal aortae. Inter-
somitic vessels irregularities were
also observed (Iyer et al. 1997; Kotch
et al., 1999). The dilatation and re-
gression of vessels in HIF-1 null mu-
tant mouse was caused by extensive
cell death of mesenchymal cells. These
defects were less severe than in the
case of VEGF null mutants (Carmeliet
et al., 1996; Ferrara et al., 1996), but
it documented that HIF-1 itself par-
ticipated not only in metabolic cellular
adaptations but also in vessel morpho-
genesis because levels of VEGF were
normal or elevated in this mutant
(Kotch et al., 1999).
In our experiment, the increased
VEGF expression correlated with in-
creased HIF-1. HIF-1 is known to
activate the transcription of VEGF
and other genes increasing O2 deliv-
ery and glycolytic enzymes (reviewed
by Blancher and Harris, 1998). How-
ever, Kotch et al. (1999) found in
HIF-1 null mutant that the VEGF
was directly induced by hypoxia or
glucose deprivation, suggesting there




In hypoxic embryos, the wall of the
ventricular myocardium was thinner
than in normoxia and was positive in
the Hypoxyprobe reaction in whole ex-
tent. This was in contrast to normoxic
embryos where only the septum and
the superficial layer of the myocar-
dium were positive. The extensive tis-
sue hypoxia was followed by over-ex-
pression of VEGF in myocardium. The
most conspicuous feature of the hy-
poxic heart was the extensive trabecu-
larization of ventricular myocardium.
It could represent an adaptive mecha-
nism, shortening the diffusion dis-
tance of oxygen for the myocardium.
Our finding of a high level of VEGF
expression in the interventricular sep-
tum correlates with the observation of
Tomanek et al. (1999) in the normoxic
heart of the quail where it was fol-
lowed by a high density of vasculariza-
tion. The overproduction of trabeculae
and increased endocardial cell prolif-
eration were also observed in quail
embryos after application of VEGF
(Feucht et al., 1997) and in mouse em-
bryos with an elevated expression of
VEGF (Miquerol et al., 2000). How-
ever, the increased level of VEGF in
these experiments resulted in cardio-
vascular malformations and embry-
onic lethality. It appears that an ade-
quate level of VEGF expression is
important for normal heart morpho-
genesis.
Another role of hypoxia in develop-
ing avian heart has been demon-
strated by Sugishita et al. (2004).
These authors have shown that re-
gional myocardial hypoxia leads to ap-
optosis of cardiomyocytes, which trig-
gers remodeling of the cardiac outflow
tract.
The Effect of Enhanced
Hypoxia
In the hypoxic condition, regions of
tissue hypoxia were more pronounced
and enlarged. It was accompanied by
more extensive HIF-1 and VEGF ex-
pression and by a higher density of
capillary plexuses.
Superficial capillary plexuses were
richer in limbs and in the trunk of
embryos incubated under hypoxia
than in normoxic conditions. Cross-
sections of extremities of hypoxic em-
bryos showed more intensive VEGF
expression in muscle primordia and in
cartilaginous skeletal primordia. The
surrounding capillary plexuses were
of richer density than in normoxic em-
bryos. The richer capillary plexuses
around the neural tube in hypoxic em-
bryos correlated with stronger VEGF
expression in the neural tube. These
findings demonstrate that enhanced
moderate hypoxia accelerates and in-
tensifies the signal cascade: hypoxia:
3 HIF-1 3 VEGF 3 vessel forma-
tion, and it supports the notion that
HIF-1 regulates the formation of
capillary networks rather than forma-
tion of larger vessels (Ryan et al.,
1988).
In the limb primordia, the HIF-1
and  expression was localized in a
strip in the axis of the zeugopodial
limb segment that was not visible in
normoxic embryos. The strip ended
distally by a dot of positivity in the
autopodial segment. This corresponds
to the course of the developing axial
arterial trunk and suggests that the
position of this artery is determined
by local hypoxia and HIF expression.
In this case, the local microenviron-
ment seems to be a factor that influ-
ences the formation not only of capil-
lary plexuses but of the large vessels
as well.
In conclusion, we have presented
evidence that small regions of tissue
hypoxia are likely to affect the angio-
genic response in quail embryos at
embryonic days 4 to 6. Factors that
activate VEGF expression and the for-
mation of capillary networks are ex-
pressed in hypoxic regions. These re-
sults document that local tissue
hypoxia is a part of the physiological
mechanism regulating embryonic ves-
sel formation.
Experimentally enhanced hypoxia
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resulted in increased levels of HIF and
VEGF followed by increased density of
developing vessels. This demonstrates
that developmental angiogenesis
could be influenced by the microenvi-
ronment and is, thus, not entirely de-
termined by genes. Experimentally
enhanced hypoxia in avian embryos
represents an amenable model for the
study of the role of hypoxia in embry-
onic angiogenesis. It is technically
easy and is avoiding any influences
from the maternal organism.
EXPERIMENTAL
PROCEDURES
The effect of hypoxia on embryonic an-
giogenesis was studied in embryos of
Japanese quail (Coturnix coturnix ja-
ponica) at embryonic day 4 (ED 4) and
6 (ED 6), i.e., at stages HH 22–24 and
28–30 (Hamburger and Hamilton,
1951). Fertilized eggs were incubated
at 38°C and 60–85% humidity under
normoxic (21 kPa) conditions for the
first 48 hr and subsequently for 48 or 96
hr under hypoxic (16%O2  16 kPa O2)
conditions. Controls were incubated in
normoxic atmospheric oxygen tension.
Western Blot Analysis
The tissue of normoxic and hypoxic
embryos were dissolved in 0.5 % SDS,
50 mM TrisHCl, pH 6.8, and total pro-
teins were determined. Protein con-
centrations were adjusted to 2 g/1 l
and 5 sample buffer was added. De-
natured lysates (100°C, 5 min) were
separated on 8% polyacrylamide gel
and proteins were transferred onto
Hybond-ECL membrane (Amersham).
Membranes were blocked with 5%
nonfat dry milk for 45 min, incubated
1 hr with the rabbit polyclonal anti-
body (Abcam No. 16535) recognizing
the HIF-1 (1:500 in PBS  0.5%
BSA) at 25°C, washed 3 in TBST (10
mM TrisHCl, pH 8.0, 150 mM NaCl,
0.2% Tween 20), and exposed to sec-
ondary anti-rabbit antibody (Amer-
sham, NA934) 1:10,000 (in PBS0.5%
BSA) for 1 hr at 25°C. Membranes
were then washed 5 in TBST, devel-
oped with ECL reagents (Amersham)
and exposed to X-ray film.
Staining With QH-1 Ab in
Paraffin Sections
Embryos were collected at appropri-
ate stages, weighed without embry-
onic membranes, fixed in 4% PFA/
PBS, and prepared for Paraplast
embedding and staining with QH1 an-
tibody (Hybridoma Bank, University
of Iowa). This antibody stains quail
vascular endothelial cells and haemo-
poietic cells (Pardanaud et al., 1987).
Paraffin sections were preblocked in
5% goat serum in PBS, and then incu-
bated 90 min with QH1-Ab (1:1,000)
at room temperature. Endogenous
peroxidase was quenched by 0.1%
H2O2 in methanol for 20 min. Second-
ary antibody (Goat anti mouse Px;
Sigma: A4416, diluted 1:200) was ap-
plied for 90 min at RT and staining
revealed by the DAB color reaction.
Staining With QH-1 on
Whole Mount Embryos
Embryos were fixed in 4% PFA/PBS/
0.1%Triton, dehydrated in methanol
and stored at 20°C. After rehydra-
tion, they were treated with Protein-
ase K (20 g/ml) for 1 min per each
embryonic HH stage at room temper-
ature and post-fixed in 4% PFA/
0.25%GA/PBS/0.1%Triton. QH1 Ab
was diluted 1:1,000 and embryos were
incubated overnight at 4°C on rotat-
ing wheel. Extensive hourly washes in
PBS/0.5%Triton were followed by
overnight incubation with secondary
Goat Anti mouse AP (DAKO D0486,
1:500) antibody in PBS/0.5%Triton at
4°C. NBT/BCIP was used as a sub-





HIF-1 rabbit polyclonal antibody
(ABCAM 16535) is predicted to react
with chick and quail due to sequence
homology (90% identity with immuno-
gen). Paraffin sections were pre-
blocked in 5% goat serum in PBS, and
then incubated with primary antibody
overnight (1:200) at 4°C. Endogenous
peroxidase was quenched by 0.1%
H2O2 in methanol for 20 min. Second-
ary antibody (Goat anti-rabbit-biotin;
Jackson 111-065-144, diluted 1:600)
was applied for 60 min at RT and
staining revealed by Extravidin/Px
followed by DAB color reaction.
ISH on Whole Mount
Embryos
In situ hybridizations with HIF-1,
HIF-1, HIF-2, and VEGF mRNA
probes were performed according to
Nieto et al. (1996). Hybridization was
performed with digoxigenin labeled
antisense riboprobes at 70°C over 1–2
days. Quail HIF-2 549 bp product of
PCR from cDNA of HH15 quail em-
bryos was cloned into pCR 2.1 vector
(Invitrogen). Primers ATATGGAC-
CAAA- CGGAATCG and CTGTCT-
TCATAG- AGGAGGTT were designed
according to quail HIF-2 mRNA (Elv-
ert et al., 1999). The other probes were
kindly provided by I. Flamme (quail
VEGF, 310-bp probe; Flamme et al.,
1995), T. Takahashi (chick HIF-1, 761
bp, GenBank: AB013746; Takahashi et
al., 2001), M. K. Walker (chick HIF-1,
584 bp, GenBank: AF348088; Catron et
al., 2001). Fab fragments of sheep anti-
body to digoxigenin conjugated to alka-
line phosphatase mediated the visual-
ization (1:5,000, Roche). Expression
patterns of the probes in both chick and
quail embryos were identical allowing
for their use in quail species.
ISH in Paraffin Sections
The sense and antisense mRNA
probes were prepared from quail
VEGF cDNA (Flamme et al.,1995; 310
bp) and labeled with digoxigenin RNA
labeling kit as recommended by the
vendor (Roche). In situ hybridization
was carried out according to Nieto et
al. (1996). Briefly: embryos were fixed
overnight at 4°C in Serras fluid
(Serra, 1946), dehydrated, embedded
in Paraplast, sectioned (14 m), and
mounted onto silanised slides. The
sections were treated with proteinase
K and post-fixed in 4% PFA. Hybrid-
ization temperature was 65°C over-
night.
After standard washing, the digoxi-
genin was detected with anti-digoxi-
genin antibody conjugated with alka-
line phosphatase (Roche) in a blocking
agent (1% bovine serum albumin in
maleate buffer) at 4°C overnight. The
antibody was visualized by BCIP/NBT
color reaction (Roche) in NTMT buffer
for 3–5 days, revealing a blue product.
Selected slides were additionally im-
munolabeled with QH1 antibody.
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Detection of Tissue Hypoxia
Hypoxyprobe 1 (pimonidazol hydro-
chloride, Natural Pharmacia Interna-
tional, Inc., Research Triangle Park,
NC) has been used according to recom-
mendations of the producer. After in-
travenous administration, it is evenly
distributed throughout the embryo.
Hypoxyprobe-1 was injected in the
vitelline (chorioallantoic) vein at ED 4
or 6 (1 g/1 l and 18 g/5 l in PBS
respectively). Embryos were re-incu-
bated for 1 hr and fixed in 4% PFA/
PBS. The reaction product was de-
tected on paraffin sections with
Hypoxyprobe-1 monoclonal antibody
(1:50) for 40 min at room temperature
and the secondary antibody conju-
gated with alkaline phosphatase (1:
300) for 1 hr at RT. The color reaction
was visualized by NBT/Xphosphate.
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